Advertisement

Topics

Invenra and QIMR Berghofer Medical Research Institute Enter Collaboration to Discover Therapeutic Antibodies Against Novel Target

14:17 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Invenra, Inc., a pre-clinical stage bio-pharmaceutical company focused on next-generation therapeutic human antibodies, bispecifics and antibody derivatives, and QIMR Berghofer Medical Research Institute (“QIMR Berghofer”), ...

Other Sources for this Article

Media Contacts
Dr. Roland Green
CEO and President
Invenra, Inc.
+1 (608) 441-8178
rgreen@invenra.com
or
Siobhan Barry
Senior Communications Officer (Media)
QIMR Berghofer
media@qimrberghofer.edu

NEXT ARTICLE

More From BioPortfolio on "Invenra and QIMR Berghofer Medical Research Institute Enter Collaboration to Discover Therapeutic Antibodies Against Novel Target"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...